CNSP · Categories · Form 4

CNSP - SEC Form 4 insider transactions

CNS Pharmaceuticals Inc. (CNSP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CNSP

• 53d
  SEC Form 4 filed by Chief Technology Officer Faulkner Eric

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 53d
  SEC Form 4 filed by Chief Financial Officer O'Loughlin Steve

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 114d
  SEC Form 4 filed by CEO and President Levin Rami

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Director Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Chief Executive Officer Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Director Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Director Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Chief Financial Officer Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Director Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 158d
  SEC Form 4 filed by Director Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 628d
  SEC Form 4 filed by Large owner Cortice Biosciences, Inc.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 746d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 810d
  SEC Form 4 filed by Mahery Amy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 927d
  SEC Form 4 filed by Gumulka Jerzy (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 927d
  SEC Form 4 filed by Evans Carl Anthony (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 927d
  SEC Form 4 filed by Keyes Jeffry R. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 927d
  SEC Form 4 filed by Charles Faith L. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 927d
  SEC Form 4 filed by Cockroft Bettina M. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 927d
  SEC Form 4 filed by Andraczke Andrzej (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 944d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 944d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 944d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 944d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 944d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 944d
  SEC Form 4 filed by Andraczke Andrzej

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 977d
  SEC Form 4: Downs Christopher bought $34,177 worth of shares (27,000 units at $1.27), increasing direct ownership by 276% to 36,772 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 984d
  SEC Form 4: Climaco John M bought $4,944 worth of shares (2,750 units at $1.80), increasing direct ownership by 6% to 49,010 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 990d
  SEC Form 4 filed by Cockroft Bettina M. (Amendment)

  4/A - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 999d
  SEC Form 4: Priebe Waldemar sold $133,114 worth of shares (94,298 units at $1.41)

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1083d
  SEC Form 4 filed by Cockroft Bettina M.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1091d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1091d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1101d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1104d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1105d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1108d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1122d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1122d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1208d
  SEC Form 4 filed by Charles Faith L.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1458d
  SEC Form 4 filed by Climaco John M

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1458d
  SEC Form 4 filed by Downs Christopher

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1504d
  SEC Form 4: Downs Christopher was granted 33,000 shares, increasing direct ownership by 22% to 184,500 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1509d
  SEC Form 4: Keyes Jeffry R. was granted 11,100 shares

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1509d
  SEC Form 4: Evans Carl Anthony was granted 3,750 shares

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1510d
  SEC Form 4: Climaco John M was granted 35,000 shares, increasing direct ownership by 4% to 940,298 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1552d
  SEC Form 4: Priebe Waldemar disposed of 1,495,867 shares

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1601d
  SEC Form 4: Downs Christopher bought $4,702 worth of shares (5,000 units at $0.94), increasing direct ownership by 3% to 151,500 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1616d
  SEC Form 4: Downs Christopher bought $5,192 worth of shares (4,500 units at $1.15), increasing direct ownership by 3% to 146,500 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1620d
  SEC Form 4: Climaco John M was granted 5,000 shares, increasing direct ownership by 0.56% to 905,298 units

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1745d
  SEC Form 4 filed by Evans Carl Anthony

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1745d
  SEC Form 4 filed by Keyes Jeffry R.

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1745d
  SEC Form 4 filed by Gumulka Jerzy

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)
• 1745d
  SEC Form 4 filed by Andraczke Andrzej

  4 - CNS Pharmaceuticals, Inc. (0001729427) (Issuer)

Other CNSP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends